influenza
virus
sarscoronaviru
sarscov
highli
transmiss
respiratori
virus
pose
seriou
threat
human
health
yearli
recur
influenza
epidem
associ
signific
morbid
mortal
particularli
among
elderli
global
spread
pandem
influenza
virus
caus
million
death
sever
acut
respiratori
syndrom
coronaviru
sarscov
caus
novel
lung
diseas
sar
emerg
spread
countri
fatal
infect
sarscov
influenza
virus
circul
anim
reservoir
water
fowl
influenza
bat
sarscov
therefor
identif
cellular
factor
essenti
viral
spread
anim
human
cell
allow
novel
approach
prevent
therapi
sarscov
spike
protein
sarss
influenza
viru
hemagglutinin
ha
insert
viral
membran
mediat
host
cell
entri
sarss
influenza
ha
bind
host
cell
receptor
sarscov
sialic
acid
membran
protein
lipid
human
influenza
virus
mediat
fusion
viral
membran
host
cell
membran
consequ
viral
compon
releas
host
cell
subvert
synthet
capabl
host
cell
product
releas
progeni
particl
influenza
ha
sarssprotein
synthes
inact
precursor
transit
activ
form
upon
cleavag
host
cell
proteas
cleavag
sarss
influenza
ha
essenti
viral
infect
respons
proteas
target
antivir
intervent
natur
incomplet
defin
recent
evid
indic
type
ii
transmembran
serin
proteas
ttsp
hat
activ
human
influenza
virus
spread
proteas
transfect
cell
addit
endogen
shown
promot
influenza
viru
spread
cell
line
sarscov
found
activ
cathepsin
l
upon
viral
uptak
host
cell
endosom
howev
sever
recent
report
demonstr
express
target
cell
render
cathepsin
activ
dispens
infecti
entri
sarscov
suggest
sarscov
influenza
virus
exploit
ttsp
promot
spread
despit
intrigu
find
made
cell
cultur
role
hat
influenza
viru
sarscov
spread
pathogenesi
remain
defin
essenti
determin
extent
hat
express
viral
target
cell
human
tissu
show
hat
coexpress
sialic
acid
key
receptor
determin
sarscov
influenza
viru
respect
major
portion
human
respiratori
tract
indic
proteas
could
support
sarscov
influenza
viru
spread
human
addit
demonstr
ha
activ
conserv
human
anim
speci
critic
involv
zoonot
transmiss
influenza
viru
underlin
potenti
import
role
proteas
influenza
viru
zoonosi
cell
obtain
american
type
cultur
collect
atcc
propag
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
penicillin
streptomycin
grown
humidifi
atmospher
analysi
cellcel
fusion
effector
cell
seed
plate
either
empti
pcdna
plasmid
plasmid
encod
sar
combin
plasmid
encod
herp
simplex
transactiv
fuse
describ
parallel
target
cell
seed
plate
transfect
plasmid
encod
indic
proteas
empti
plasmid
togeth
plasmid
encod
promot
five
bind
site
front
luciferas
gene
transfect
effector
target
cell
mix
incub
trypsin
pb
fusion
quantifi
determin
luciferas
activ
cell
lysat
h
cocultiv
use
commerci
avail
kit
promega
madison
usa
gener
lentivir
pseudoparticl
transfect
perform
describ
briefli
cell
transient
cotransfect
er
luc
express
plasmid
code
influenza
viru
ha
neuraminidas
na
vesicular
stomat
viru
glycoprotein
vsvg
analysi
ha
activ
ttsp
express
plasmid
indic
proteas
empti
vector
cotransfect
cell
produc
pseudoparticl
cultur
medium
replac
h
harvest
h
post
transfect
supernat
pass
filter
store
infect
pseudoparticl
treat
either
pb
trypsin
follow
incub
target
cell
three
day
cell
lyse
luciferaseact
determin
use
commerci
avail
kit
promega
madison
usa
detect
ha
sarsscleavag
ci
cell
cotransfect
plasmid
encod
sarss
ha
plasmid
encod
indic
proteas
empti
vector
pcdna
analysi
sarss
cleavag
tran
plasmid
encod
sarss
proteas
transfect
separ
cell
follow
mix
transfect
cell
subsequ
cell
treat
pb
trypsin
lyse
separ
via
sdspage
transfer
onto
nitrocellulos
membran
sarss
detect
stain
rabbit
serum
rais
subunit
sarss
subunit
detect
ha
mous
monoclon
antibodi
use
load
control
strip
membran
incub
antibodi
sigma
deisenhofen
germani
bound
antibodi
detect
hrpcoupl
secondari
antibodi
dianova
hamburg
germani
formalin
fix
paraffin
embed
tissu
sampl
wide
rang
tissu
respiratori
gastrointestin
tract
well
myocardium
obtain
oxford
radcliff
biobank
full
ethic
approv
nation
research
ethic
servic
oxfordshir
research
ethic
committe
refer
patient
gave
gener
consent
use
tissu
research
time
sign
consent
form
surgeri
inform
consent
patient
use
tissu
studi
requir
nation
research
ethic
servic
tissu
anonymis
tissu
section
immunostain
hat
elderberri
lectin
sambucu
nigra
detect
sialic
acid
antigen
retriev
perform
pressur
cook
differ
antigen
retriev
solut
slide
mount
aquatex
mount
medium
merck
uk
immunostain
affin
purifi
goat
polyclon
serum
r
system
abingdon
uk
perform
detect
use
mous
antigoat
ig
max
polym
detect
system
leica
microsystem
newcastl
uk
per
manufactur
instruct
antigen
retriev
citrat
ph
mous
monoclon
antibodi
ascit
gener
gift
dr
jm
luca
divis
human
biolog
fred
hutchinson
cancer
research
center
seattl
wa
usa
immunostain
detect
use
novolinktm
max
polym
detect
system
antigen
retriev
tri
edta
hat
immunostain
mous
monoclon
antibodi
r
system
abingdon
uk
perform
use
max
polym
detect
system
antigen
retriev
dako
target
retriev
solut
ph
dako
cambridg
uk
biotinyl
elderberri
lectin
sambucu
nigra
vector
lab
peterborough
uk
bind
detect
use
streptavidinhrp
arm
limit
egham
uk
detect
use
dako
dab
chromogen
substrat
dako
cambridg
uk
antigen
retriev
trisedta
ph
lung
tissu
use
posit
control
elderberri
lectin
stain
bronchu
use
posit
control
hat
immunostain
neg
control
immunostain
elderberri
lectin
stain
normal
goat
polyclon
serum
substitut
primari
antibodylectin
stain
step
neg
control
hat
immunostain
irrelev
mous
monoclon
antibodi
clone
substitut
primari
antibodi
stain
section
photograph
nikon
camera
nikon
control
unit
nikon
uk
limit
kingstonupontham
uk
olympu
microscop
olympu
uk
limit
watford
uk
influenza
virus
circul
bird
poultri
water
fowl
constitut
natur
reservoir
coinfect
swine
differ
influenza
virus
believ
play
import
role
emerg
pandem
virus
hat
shown
activ
influenza
viru
transfect
cell
evid
potenti
contribut
viral
spread
human
report
order
assess
role
influenza
viru
zoonosi
test
whether
proteas
deriv
chicken
swine
abl
cleav
ha
parallel
examin
mous
origin
facilit
ha
proteolysi
sinc
mice
commonli
use
model
system
influenza
viru
spread
pathogenesi
final
cleavag
activ
ha
human
mous
hat
also
evalu
western
blot
analysi
transfect
cell
reveal
hat
anim
speci
test
cleav
ha
precursor
produc
cleavag
fragment
ident
observ
human
enzym
fig
slightli
faster
migrat
fragment
gener
compar
proteas
due
differenti
ha
glycosyl
cleavag
result
ha
activ
sinc
lentivir
vector
produc
proteas
express
cell
fulli
infecti
absenc
trypsin
treatment
fig
contrast
ha
cleavag
activ
observ
cell
transfect
empti
vector
cell
express
human
fig
b
previous
demonstr
process
ha
similarli
swine
chicken
mous
cleav
sarss
multipl
fragment
previous
document
human
although
variat
cleavag
effici
note
fig
contrast
trypsin
digest
produc
subunit
expect
note
sarss
cleav
upon
coexpress
protein
ci
cleavag
figur
upon
mix
sarss
express
cell
proteas
express
cell
tran
cleavag
fig
although
variabl
cleavag
effici
note
latter
set
agreement
sarss
tran
cleavag
express
target
cell
panel
endogen
express
low
amount
viral
receptor
allow
effici
sarssdriven
cellcel
fusion
fusion
effici
increas
addit
trypsin
contrast
sarssdriven
fusion
control
transfect
cell
pcdna
panel
ineffici
fusion
effici
rescu
trypsin
treatment
fig
final
transfect
plasmid
target
cell
panel
also
boost
cellcel
fusion
fusion
effici
modestli
increas
trypsin
agreement
previou
find
receptor
proteas
express
target
cell
limit
sarssmedi
cellcel
fusion
sum
result
demonstr
cleavageactiv
influenza
ha
sarss
conserv
human
porcin
avian
murin
well
human
murin
hat
observ
also
suggest
support
influenza
viru
spread
speci
integr
influenza
zoonosi
mice
suitabl
model
studi
role
hat
viral
spread
pathogenesi
bind
human
influenza
virus
sialic
acid
present
protein
lipid
host
cell
surfac
critic
infecti
viral
entri
host
cell
assess
whether
hat
coexpress
sialic
acid
human
tissu
immunostain
demonstr
presenc
sialic
acid
surfac
almost
cell
type
fig
keep
previou
result
notabl
except
vascular
smooth
muscl
cell
data
shown
suggest
express
proteas
hat
sialic
acid
like
major
determin
viral
tropism
express
epitheli
cell
site
examin
aerodigest
tract
well
mani
endotheli
cell
myocyt
blood
vessel
leucocyt
includ
alveolar
macrophag
smooth
muscl
cell
fig
tabl
indic
could
activ
influenza
viru
permiss
epithelia
hat
show
distribut
similar
fig
tabl
immunostain
pneumocyt
alveolar
epitheli
cell
weaker
impli
low
level
proteas
express
site
fig
c
unlik
appear
express
major
type
pneumocyt
hat
express
fewer
type
pneumocyt
addit
seen
express
occasion
type
pneumocyt
fig
c
type
pneumocyt
defin
morpholog
rather
particular
immunophenotyp
plump
rather
flatten
epitheli
cell
section
examin
experienc
consult
pathologist
es
order
identifi
cell
type
immunoposit
exact
intens
stain
hat
variou
epitheli
type
aerodigest
tract
summar
tabl
express
bronchial
intestin
smooth
muscl
cell
note
cell
appear
neg
hat
although
vascular
smooth
muscl
cell
found
posit
tabl
interestingli
hat
express
cardiac
myocyt
fig
suggest
influenza
myocard
might
promot
hat
notwithstand
data
demonstr
potenti
import
proteas
influenza
infect
target
cell
activ
sarss
adjac
cell
cellcel
fusion
activ
virionassoci
sarss
infecti
host
cell
entri
wide
rang
site
demonstr
coexpress
could
thu
support
sarscov
spread
tabl
specif
lung
type
type
pneumocyt
express
molecul
alveolar
macrophag
epitheli
cell
intrapulmonari
bronchi
fig
b
upper
respiratori
tract
epithelium
bronchi
larynx
nasal
mucosa
respiratori
sinus
fig
e
f
express
molecul
express
absent
trachea
vocal
fold
epiglotti
although
previou
studi
ren
et
al
demonstr
express
surfac
epithelium
mucu
gland
epithelium
trachea
similar
find
larynx
bronchu
suggest
express
may
variabl
widespread
upper
airway
epithelia
tonsil
fig
b
buccal
mucosa
fig
f
express
addit
express
interstiti
macrophagesdendrit
cell
intraalveolar
septa
lung
adjac
type
pneumocyt
gastrointestin
tract
epitheli
coexpress
identifi
site
examin
name
oesophagu
stomach
ileum
colon
two
molecul
also
express
cardiac
myocyt
furthermor
variabl
express
molecul
endotheli
cell
myoct
blood
vessel
leucocyt
smooth
muscl
cell
seen
fig
tabl
taken
togeth
result
suggest
could
promot
sarscov
spread
import
target
site
gastrointestin
respiratori
tract
tabl
influenza
viru
sarscov
hijack
host
cell
proteas
acquir
infect
influenza
shown
broad
spectrum
proteas
inhibitor
therapeut
potenti
howev
proteas
respons
viral
activ
infect
host
unclear
although
sever
candid
suggest
recent
studi
demonstr
hat
activ
influenza
viru
sarscoronaviru
cell
cultur
show
proteas
express
receptorposit
cell
throughout
human
respiratori
tract
might
thu
support
influenza
viru
sarscov
spread
individu
addit
influenza
viru
activ
conserv
orthologu
human
porcin
avian
origin
suggest
zoonot
transmit
influenza
virus
may
engag
facilit
activ
influenza
virus
usual
replic
tracheaobronchi
epithelium
spread
tissu
might
support
hat
found
express
cell
posit
sialic
acid
nasal
buccal
mucosa
well
epithelium
trachea
bronchu
larynx
infect
associ
pneumonia
complic
frequent
observ
pandem
compar
season
influenza
virus
viral
spread
alveolar
epithelium
observ
type
pneumocyt
suggest
major
target
influenza
viru
alveoli
found
posit
sialic
acid
studi
proteas
respons
ha
activ
cell
remain
defin
sinc
absent
cell
type
express
hat
infrequ
weak
howev
studi
found
type
ii
pneumocyt
preferenti
infect
cell
identifi
posit
sialic
acid
occasion
hat
within
present
studi
presenc
cell
posit
sialic
acid
andor
hat
limit
respiratori
tract
keep
publish
find
demonstr
express
epithelia
sever
organ
therefor
tempt
specul
hat
might
also
support
viral
spread
outsid
lung
might
thu
contribut
complic
associ
influenza
infect
like
gastrointestin
manifest
myocard
encephalopathi
sum
except
alveolar
epithelium
hat
could
activ
influenza
virus
throughout
respiratori
tract
might
support
viral
spread
extrarespiratori
tissu
mode
cleavag
activ
major
virul
determin
avian
influenza
virus
virus
multibas
cleavag
site
ha
believ
activ
ubiquit
express
host
cell
proteas
thu
replic
system
caus
sever
diseas
contrast
posit
replic
virus
monobas
cleavag
site
confin
aerodigest
tract
express
yet
unidentifi
haactiv
proteas
limit
organ
result
suggest
could
elus
proteas
remain
demonstr
whether
express
waterfowl
poultri
inde
specif
aerodigest
tract
ha
activ
conserv
avian
porcin
human
share
high
sequenc
ident
see
figur
indic
might
support
influenza
viru
spread
reservoir
waterfowl
human
also
import
intermedi
host
swine
sarscov
caus
sever
respiratori
ill
fatal
outcom
afflict
individu
metalloproteas
identifi
sarscov
receptor
express
type
ii
pneumocyt
major
viral
target
cell
pulmonari
cell
demonstr
cornerston
studi
simmon
colleagu
show
infecti
sarscov
entri
cell
line
depend
activ
endosom
cathepin
particularli
cathepsin
l
suggest
cathepsin
activ
might
requir
viral
spread
respiratori
tract
howev
sever
studi
show
activ
sarscov
cathepsinindepend
host
cell
entri
demonstr
express
type
ii
pneumocyt
addit
recent
report
indic
hat
promot
sarssdriven
cellcel
viruscel
fusion
thu
sarscov
may
use
ttsp
addit
instead
cathepsin
ensur
activ
key
target
cell
analysi
confirm
extend
find
demonstr
coexpress
cell
nasal
buccal
mucosa
well
epithelia
bronchu
larynx
thu
one
specul
context
infect
host
cathepsin
activ
might
essenti
sarscov
spread
part
respiratori
tract
experi
cathepsin
inhibitor
knockout
mice
requir
address
possibl
gastrointestin
tract
wellestablish
target
sarscov
actual
suggest
wide
rang
tissu
organ
infect
viru
find
coexpress
colon
variou
tissu
indic
also
extrarespiratori
spread
sarscov
might
promot
collect
find
compat
import
role
hat
influenza
viru
sarscoronaviru
infect
knock
proteas
primari
pulmonari
cell
analysi
knockout
mice
would
allow
precis
definit
role
proteas
viral
spread
latter
anim
avail
show
obviou
phenotyp
indic
might
attract
target
novel
drug
activ
respiratori
virus
